Group 1 - The article highlights a significant increase in stock prices for various biotech companies, with Chengdu XianDao and Rejing Bio rising over 12%, and several others showing gains of 3% to 9% [1] - The Super Flu is spreading globally, with the U.S. reporting over 7.5 million cases this flu season, leading to over 80,000 hospitalizations and 3,100 deaths, primarily driven by the H3N2 virus variant [1] - A new national medical insurance drug list has been implemented, adding 114 new drugs, including 50 first-class new drugs, marking a record high in both quantity and proportion [1] Group 2 - The latest batch of centralized procurement will be implemented in February 2026, covering 55 essential drugs, including those for chronic diseases and pediatric use [2] - The medical device price governance will enter a new phase in 2026, with some products seeing price reductions exceeding 97%, establishing a minimum price threshold [2] - The healthcare service landscape is improving, with new regulations mandating that primary healthcare institutions must equip at least five categories of antihypertensive drugs by March 2026 [2]
国际铜价首次触及每吨 13000 美元历史关口，稀有金属 ETF（562800）投资机遇凸显
Sou Hu Cai Jing·2026-01-07 03:50